Related Experiment Video
Updated: Aug 3, 2026
07:46
Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
Published on: October 22, 2015
Exercise activates the endocannabinoid system
P B Sparling1, A Giuffrida, D Piomelli
1School of Applied Physiology, Georgia Institute of Technology, Atlanta, GA 30332, USA.
Neuroreport
|November 20, 2003
Summary
Moderate-intensity exercise activates the endocannabinoid system, offering a new explanation for exercise-induced pain relief and sedation. This research provides the first evidence linking physical activity to this crucial neurochemical pathway.
Area of Science:
- Exercise physiology
- Neuroendocrinology
- Sports medicine
Background:
- Exercise is known to induce analgesia and sedation.
- The underlying neurochemical mechanisms remain largely unknown despite extensive research.
- Understanding these mechanisms is crucial for explaining physiological and psychological adaptations to exercise.
Purpose of the Study:
- To investigate the neurochemical basis of exercise-induced analgesia and sedation.
- To determine if moderate-intensity exercise activates the endocannabinoid system.
- To propose a novel mechanism for exercise-induced physiological and psychological effects.
Main Methods:
- Trained male college students participated in the study.
- Participants engaged in 50 minutes of exercise at 70-80% of maximum heart rate.
- Exercise modalities included treadmill running and stationary cycling.
Main Results:
- The study provides the first evidence that moderate-intensity exercise activates the endocannabinoid system.
- This activation suggests a new neurochemical pathway for exercise-induced analgesia.
- The findings may also explain other physiological and psychological adaptations to exercise.
Conclusions:
- Moderate-intensity exercise activates the endocannabinoid system.
- The endocannabinoid system represents a potential mechanism for exercise-induced analgesia and sedation.
- Further research is warranted to explore the full implications of this finding for exercise adaptation.
Related Concept Videos
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...